Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01793246 · ClinicalTrials.gov registry record
Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung
A clinical trial, sponsored by Mauna Kea Technologies.
- Completed
- Registry status
- 99
- Enrollment target
NCT01793246: Completed study, sponsored by Mauna Kea Technologies.
NCT01793246 is a clinical trial that has completed, run by Mauna Kea Technologies. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01793246 has completed, sponsored by Mauna Kea Technologies.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
Patients will be enrolled that are undergoing bronchoscopy for diagnosis of discrete lung lesions or for detection of acute rejection following lung transplants. The hypothesis is that bronchoscopy together with probe-based endomicroscopy (pCLE)results in improved and/or incremental diagnostic yield (definitive diagnosis) over conventional bronchoscopy.
Primary Outcome
For Group 1 - Discrete lung lesions
Interventions
- DEVICE probe based laser endomicroscopy (pCLE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-12-24 |
What the finished NCT01793246 record still lists
NCT01793246 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which probe based laser endomicroscopy (pCLE) is the first listed.
NCT01793246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01793246 about?
NCT01793246 is a clinical study titled "Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung". Patients will be enrolled that are undergoing bronchoscopy for diagnosis of discrete lung lesions or for detection of acute rejection following lung transplants. The hypothesis is that bronchoscopy together with probe-based endomicroscopy (pCLE)results in improved and/or incremental diagnostic yield...
What is the current status of trial NCT01793246?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2013-02. Estimated completion is 2016-12-24.
What interventions are being tested in trial NCT01793246?
The interventions under investigation include: probe based laser endomicroscopy (pCLE) (DEVICE).
Who is sponsoring clinical trial NCT01793246?
This trial is sponsored by Mauna Kea Technologies, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia